Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hayden

Showing results (71-80 of 391) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|December 15, 2010
Emerging influenza antiviral resistance threatsFrederick G Hayden, Menno D de Jong
Annals of Internal Medicine|May 1, 1997
Zinc gluconate lozenges for treating the common coldB M Farr, F G Hayden, J Gwaltney
Antimicrobial Agents and Chemotherapy|June 1, 1994
Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A moleculeC E Crump, E Arruda, F G Hayden
The American Surgeon|June 1, 1974
Left ventriculoaortic shunting: a laboratory investigationW G Hayden, S Hirshorn, R H Blank
Influenza and Other Respiratory Viruses|August 19, 2011
Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USAWendy A Howard, Malik Peiris, Frederick G Hayden
The Journal of Infectious Diseases|March 27, 2012
Combination antiviral therapy for influenza: predictions from modeling of human infectionsAlan S Perelson, Libin Rong, Frederick G Hayden
Antimicrobial Agents and Chemotherapy|October 1, 1980
Enhancement of activity against influenza viruses by combinations of antiviral agentsF G Hayden, R G Douglas, R Simons
Acta Psychologica|March 1, 1980
Sensory modality and method of item information presentation in memoryC Izawa, R G Hayden, K L Isham
The Journal of Infectious Diseases|January 12, 2017
Experimental Therapies for Ebola Virus Disease: What Have We Learned?Frederick G Hayden, Martin Friede, Daniel G Bausch
Antimicrobial Agents and Chemotherapy|April 1, 1992
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infectionF G Hayden, K Andries, P A Janssen
Pageof 40

Showing results (71-80 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|December 15, 2010
Emerging influenza antiviral resistance threatsFrederick G Hayden, Menno D de Jong
Annals of Internal Medicine|May 1, 1997
Zinc gluconate lozenges for treating the common coldB M Farr, F G Hayden, J Gwaltney
Antimicrobial Agents and Chemotherapy|June 1, 1994
Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A moleculeC E Crump, E Arruda, F G Hayden
The American Surgeon|June 1, 1974
Left ventriculoaortic shunting: a laboratory investigationW G Hayden, S Hirshorn, R H Blank
Influenza and Other Respiratory Viruses|August 19, 2011
Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USAWendy A Howard, Malik Peiris, Frederick G Hayden
The Journal of Infectious Diseases|March 27, 2012
Combination antiviral therapy for influenza: predictions from modeling of human infectionsAlan S Perelson, Libin Rong, Frederick G Hayden
Antimicrobial Agents and Chemotherapy|October 1, 1980
Enhancement of activity against influenza viruses by combinations of antiviral agentsF G Hayden, R G Douglas, R Simons
Acta Psychologica|March 1, 1980
Sensory modality and method of item information presentation in memoryC Izawa, R G Hayden, K L Isham
The Journal of Infectious Diseases|January 12, 2017
Experimental Therapies for Ebola Virus Disease: What Have We Learned?Frederick G Hayden, Martin Friede, Daniel G Bausch
Antimicrobial Agents and Chemotherapy|April 1, 1992
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infectionF G Hayden, K Andries, P A Janssen
Pageof 40